NCT04527133View on ClinicalTrials.gov

An Open Non-comparative Study of the Efficacy and Safety of Aprotinin in Patients Hospitalized With COVID-19

NAUnknownINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 11, 2020

Primary Completion Date

August 11, 2020

Study Completion Date

August 31, 2020

Conditions
COVID-19
Interventions
DRUG

Aprotinin

Intravenous or inhalation

Trial Locations (1)

Unknown

"Regional State Budgetary Healthcare Institution Clinical Hospital №1", Smolensk

Sponsors

Lead Sponsor

Aviron LLC
All Listed Sponsors
lead

Aviron LLC

INDUSTRY

NCT04527133 - An Open Non-comparative Study of the Efficacy and Safety of Aprotinin in Patients Hospitalized With COVID-19 | Biotech Hunter | Biotech Hunter